- Prophylactic Effect of Pegfilgrastim on Febrile Neutropenia in Patients with Non-Hodgikin's Lymphoma
-
Jo J, Bang JS
- KMID: 2068831
- Korean J Clin Pharm.
- 2015 Jun;25(2):80-93.
- doi: 10.0000/kjcp.2015.25.2.80
OBJECTIVE: Pegfilgrastim is recently introduced that is long acting G-CSF for prophylaxis of febrile neutropenia. Treatment of non-Hodgikin's lymphoma (NHL) with R-CHOP is classified with relative high risk of febrile... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Empirical Antibiotics in Febrile Neutropenia
-
Lee JS, Lim YT
- KMID: 2207830
- J Korean Pediatr Soc.
- 1998 Sep;41(9):1209-1215.
PURPOSE: This study was designed to evaluate the safety and efficacy of early cessation of antibiotic treatment regardless of absolute neutrophil count in children with febrile neutropenia and no identifiable... -
- CITED
-
- Close
- SHARE
-
- Close
- The Risk Factor of Bacteremia in Children with Febrile Neutropenia due to Chemotherapy
-
Kim TH, Lee YH
- KMID: 2207895
- J Korean Pediatr Soc.
- 1998 May;41(5):677-683.
PURPOSE: We evaluated the easily-assessable risk factors to predict bacteremia in children with febrile neutropenia, who received anticancer chemotherapy. METHODS: We retrospectively reviewed 46 children who had febrile neutropenia caused... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Cefepime Monotherapy with Piperacillin-Tazobactam, Gentamicin Combination Therapy in Pediatric Cancer Patients with Febrile Neutropenia
-
Lee SY, Yun YS, Kim SY, Park KD
- KMID: 2278335
- Korean J Pediatr Hematol Oncol.
- 2005 Apr;12(1):63-69.
PURPOSE: Cefepime is a new broad-spectrum antibiotics and is available as initial monotherapy in the management of pediatric cancer patients with febrile neutropenia. The aim of this study is to... -
- CITED
-
- Close
- SHARE
-
- Close
- The Characteristics of Febrile Neutropenia Induced by Chemotherapy
-
Sohn HJ, Yoo KH, Lee GC, Kim SG
- KMID: 2335297
- J Korean Pediatr Soc.
- 1997 Oct;40(10):1443-1452.
PURPOSE: The development of fever in neutropenic cancer patients is frequently a sign of infection. Infection remains the major cause of death in the patient with cancer, primarily as a... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of colony-stimulating factor in patients with ovarian cancer receiving paclitaxel and carboplatin in Japan
-
Harano K, Hirakawa A, Kato T, Suzuki K, Watanabe S, Katsumata
- KMID: 1708335
- J Gynecol Oncol.
- 2014 Apr;25(2):124-129.
- doi: 10.3802/jgo.2014.25.2.124
OBJECTIVE: To assess the use of colony-stimulating factors (CSFs) in patients with ovarian cancer who receive adjuvant paclitaxel and carboplatin chemotherapy in clinical practice and to assess whether the frequency... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacies of Teicoplanin in Patients with Febrile Neutropenia
-
Lee DG, Yim DS, Choi SM, Park SH, Yoo JH, Choi JH, Min WS, Shin WS, Kim CC
- KMID: 2170096
- Infect Chemother.
- 2004 Apr;36(2):83-91.
BACKGROUND: This study was done to elucidate the efficacy of teicoplanin as the empirical treatment for febrile neutropenia. METHODS: Patients were randomized to two groups according to pharmaceutical company (company A... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Prediction Factors in Febrile Neutropenic Patients
-
Jung JS, Kwon KY, Kim KS, Lim YS, Rhee JE, Suh GJ, Youn YK
- KMID: 2194370
- J Korean Soc Emerg Med.
- 2000 Sep;11(3):305-315.
BACKGROUND: Most febrile neutropenic patients are treated in an aggressive manner. However, identification of low-risk patients may enable clinicians to administer risk-based treatment. The object of this study is to... -
- CITED
-
- Close
- SHARE
-
- Close
- Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
-
Choi YW, Jeong SH, Ahn MS, Lee HW, Kang SY, Choi JH, Jin UR, Park JS
- KMID: 2069930
- J Korean Med Sci.
- 2014 Nov;29(11):1493-1500.
- doi: 10.3346/jkms.2014.29.11.1493
Febrile neutropenia (FN) is the major toxicity of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) regimen in the treatment of diffuse large B-cell lymphoma (DLBCL). The prediction of neutropenia... -
- CITED
-
- Close
- SHARE
-
- Close
- Pegfilgrastim for primary prophylaxis of febrile neutropenia in breast cancer patients undergoing TAC chemotherapy
-
Lee J, Lee JE, Kim Z, Han SW, Hur SM, Kim SY, Lee MH, Lim CW
- KMID: 2410264
- Ann Surg Treat Res.
- 2018 May;94(5):223-228.
- doi: 10.4174/astr.2018.94.5.223
PURPOSE: Primary prophylaxis with granulocyte colony-stimulating factor can effectively prevent febrile neutropenia (FN) during breast cancer treatment. The aims of this study were to evaluate the incidence of FN and... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Pneumocystis carinii Pneumonia with Febrile Neutropenia in Acute Lymphoblastic Leukemia
-
Choi YH, Min KS, Kim JW, Kim KN, Ryoo KY
- KMID: 2440372
- Korean J Pediatr Infect Dis.
- 1997 May;4(1):174-182.
- doi: 10.14776/kjpid.1997.4.1.174
Pneumocystis carinii pneumonia mainly occurs in immunocompromised patients and it is also known of major cause of death in children with acute lymphoblastic leukemia. After consolidation chemotherapy, acute lymphoblastic leukemia... -
- CITED
-
- Close
- SHARE
-
- Close
- The Importance of Laminar Air Flow Reverse Isolation for Febrile Neutropenic Patients
-
Kim HS, Lee JH, Lee KS
- KMID: 2134649
- Clin Pediatr Hematol Oncol.
- 2006 Oct;13(2):199-207.
PURPOSE: The aim of this study is to find out the role of laminar air flow with HEPA filter room reverse isolation in the treatment of chemotherapy-induced febrile neutropenic children... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy
-
Kim CG, Sohn J, Chon H, Kim JH, Heo SJ, Cho H, Kim IJ, Kim SI, Park S, Park HS, Kim GM
- KMID: 2176324
- J Breast Cancer.
- 2016 Mar;19(1):76-82.
- doi: 10.4048/jbc.2016.19.1.76
PURPOSE: Doxorubicin/cyclophosphamide followed by docetaxel chemotherapy (AC-D) is an intermediate risk factor (incidence of 10%–20%) for febrile neutropenia (FN) in breast cancer. However, the reported incidence of FN while using... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors associated with Oncology Nurses' Adherence to Chemotherapy-Induced Neutropenia Guidelines based on Pender's Health Promotion Model
-
Kim GJ, Choi JY
- KMID: 2455721
- Korean J Adult Nurs.
- 2019 Aug;31(4):389-402.
- doi: 10.7475/kjan.2019.31.4.389
PURPOSE: This study was conducted to identify factors associated with oncology nurses' adherence to Chemotherapy-Induced Neutropenia (CIN) guidelines based on Pender's Health Promotion Model (HPM). METHODS: For this cross-sectional descriptive study,... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of Febrile Neutropenia in Advanced Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy in Korea and Its Impact on Prognosis
-
Park BK, Gwak H, Lim ST, Suh YJ, Jeon YW
- KMID: 2470609
- J Breast Dis.
- 2019 Dec;7(2):97-104.
- doi: 10.14449/jbd.2019.7.2.97
PURPOSE: The concurrent regimen of docetaxel, doxorubicin, and cyclophosphamide (TAC) has been categorized as a high-risk factor for febrile neutropenia (FN). The incidence of FN was reported to be as... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Efficacy and Safety of Cefepime alone Versus Ceftazidime Plus Tobramycin in Cancer Patients with Febrile Neutropenia
-
Jung HW, Chae JW, Kang MR, Yang JC, Moon CS, Ki HK, Chang HH, Oh WS, Kim K, Peck KR, Lee NY, Song JH
- KMID: 1808203
- Infect Chemother.
- 2004 Dec;36(6):341-349.
BACKGROUND: Broad-spectrum antibiotic therapy has been recommended as an empirical regimen in cancer patients with febrile neutropenia. Cefepime is a fourth generation cephalosporin with good activity against both gram-positive cocci... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Manifestations of Febrile Neutropenic Patients with Solid Tumor and Risk Factors for Gram Positive Bacteremia
-
Ku NS, Kim JH, Choi YK, Jung SJ, Oh HJ, Yoon KT, Kim YA, Shin SY, Kim MS, Kim YK, Park YS, Choi JY, Song YG, Lee K, Kim JM
- KMID: 2054316
- Infect Chemother.
- 2006 Oct;38(5):250-258.
BACKGROUNDS: Recently, there has been a rise of prevalence of gram positive infection among cancer patients with febrile neutropenia. The proportion of antibiotic-resistant gram positive infection has been growing lately,... -
- CITED
-
- Close
- SHARE
-
- Close
- Docetaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer
-
Jeon SB, Ahn BM, Mun JH, Sung WJ, Kim DH, Kim JG, Kim TB, Jung HY, Yu WS, Sohn SK, Lee KB
- KMID: 1833287
- Korean J Med.
- 2005 Jun;68(6):672-677.
BACKGROUND: We evaluated the efficacy and toxicity of docetaxel plus cisplatin combination as first-line chemotherapy for advanced gastric cancer. METHODS: Patients with metastatic or recurrent gastric adenocarcinoma, performance score -
- CITED
-
- Close
- SHARE
-
- Close
- Induction chemotherapy in patients with locally-advanced head and neck squamous cell carcinoma: docetaxel and cisplatin
-
Choi YJ, Shin HJ, Chung JS, Cho GJ, Lee BJ, Wang SG
- KMID: 2257829
- Korean J Med.
- 2007 Oct;73(4):415-422.
BACKGROUND: This prospective study was conducted to assess the efficacy and toxicity of induction chemotherapy with docetaxel and cisplatin for patients with previously untreated, locally advanced squamous cell carcinoma of... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute Precursor T Cell Lymphoblastic Leukemia Associated with Behcet's Disease: A Case Report
-
Kim JW, Pyo JH, Kim KJ, Kim H, Jeoung Y, Ji JD, Lee YH
- KMID: 2222990
- J Rheum Dis.
- 2014 Feb;21(1):46-49.
- doi: 10.4078/jrd.2014.21.1.46
Behcet's disease is an inflammatory disorder characterized by recurrent oral aphthous ulcers, genital ulcers, uveitis, and skin lesions. A few cases of hematologic disease in patients with Behcet's disease have... -
- CITED
-
- Close
- SHARE
-
- Close
